 | | FWC | | Name: | N-Methylanthraniloyl-CoA | | Formula: | C29 H43 N8 O17 P3 S | | SMILES: | CNc1ccccc1C(=O)SCCNC(=O)CCNC(=O)[CH](O)C(C)(C)CO[P](O)(=O)O[P](O)(=O)OC[CH]2O[CH]([CH](O)[CH]2O[P](O)(O)=O)n3cnc4c(N)ncnc34 | | InChi: | InChI=1S/C29H43N8O17P3S/c1-29(2,23(40)26(41)33-9-8-19(38)32-10-11-58-28(42)16-6-4-5-7-17(16)31-3)13-51-57(48,49)54-56(46,47)50-12-18-22(53-55(43,44)45)21(39)27(52-18)37-15-36-20-24(30)34-14-35-25(20)37/h4-7,14-15,18,21-23,27,31,39-40H,8-13H2,1-3H3,(H,32,38)(H,33,41)(H,46,47)(H,48,49)(H2,30,34,35)(H2,43,44,45)/t18-,21-,22-,23+,27-/m1/s1 | | Definition date: | 2020-06-25 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | ~{S}-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] 2-(methylamino)benzenecarbothioate |
|
 | | H5O | | Name: | (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-5-methoxy-6-[(3R,4R,5S)-4-oxidanyl-5-(4-pyrimidin-5-yl-1,2,3-triazol-1-yl)oxan-3-yl]sulfanyl-4-[4-[3,4,5-tris(fluoranyl)phenyl]-1,2,3-triazol-1-yl]oxan-3-ol | | Formula: | C26 H27 F3 N8 O6 S | | SMILES: | CO[CH]1[CH](O[CH](CO)[CH](O)[CH]1n2cc(nn2)c3cc(F)c(F)c(F)c3)S[CH]4COC[CH]([CH]4O)n5cc(nn5)c6cncnc6 | | InChi: | InChI=1S/C26H27F3N8O6S/c1-41-25-22(37-7-16(32-35-37)12-2-14(27)21(29)15(28)3-12)24(40)19(8-38)43-26(25)44-20-10-42-9-18(23(20)39)36-6-17(33-34-36)13-4-30-11-31-5-13/h2-7,11,18-20,22-26,38-40H,8-10H2,1H3/t18-,19+,20+,22-,23+,24-,25+,26-/m0/s1 | | Definition date: | 2020-11-12 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | (2~{R},3~{R},4~{S},5~{R},6~{S})-2-(hydroxymethyl)-5-methoxy-6-[(3~{R},4~{R},5~{S})-4-oxidanyl-5-(4-pyrimidin-5-yl-1,2,3-triazol-1-yl)oxan-3-yl]sulfanyl-4-[4-[3,4,5-tris(fluoranyl)phenyl]-1,2,3-triazol-1-yl]oxan-3-ol |
|
 | | QDZ | | Name: | ~{N},~{N}-dimethyl-1-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]methanamine | | Formula: | C21 H21 N7 | | SMILES: | CN(C)Cc1cnn(c1)c2ccnc3[nH]c(nc23)c4cccc5n(C)ccc45 | | InChi: | InChI=1S/C21H21N7/c1-26(2)12-14-11-23-28(13-14)18-7-9-22-21-19(18)24-20(25-21)16-5-4-6-17-15(16)8-10-27(17)3/h4-11,13H,12H2,1-3H3,(H,22,24,25) | | Definition date: | 2020-06-09 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | ~{N},~{N}-dimethyl-1-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]methanamine |
|
 | | QE2 | | Name: | 5-fluoranyl-2-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonylamino)benzoic acid | | Formula: | C17 H16 F N O4 S | | SMILES: | OC(=O)c1cc(F)ccc1N[S](=O)(=O)c2ccc3CCCCc3c2 | | InChi: | InChI=1S/C17H16FNO4S/c18-13-6-8-16(15(10-13)17(20)21)19-24(22,23)14-7-5-11-3-1-2-4-12(11)9-14/h5-10,19H,1-4H2,(H,20,21) | | Definition date: | 2020-06-09 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 5-fluoranyl-2-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonylamino)benzoic acid |
|
 | | QE5 | | Name: | 2-[(3,4-dimethylphenyl)sulfonylamino]-5-fluoranyl-benzoic acid | | Formula: | C15 H14 F N O4 S | | SMILES: | Cc1ccc(cc1C)[S](=O)(=O)Nc2ccc(F)cc2C(O)=O | | InChi: | InChI=1S/C15H14FNO4S/c1-9-3-5-12(7-10(9)2)22(20,21)17-14-6-4-11(16)8-13(14)15(18)19/h3-8,17H,1-2H3,(H,18,19) | | Definition date: | 2020-06-10 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 2-[(3,4-dimethylphenyl)sulfonylamino]-5-fluoranyl-benzoic acid |
|
 | | QEK | | Name: | 2-[[3-chloranyl-4-[(1~{H}-indazol-3-ylcarbonylamino)methyl]phenyl]sulfonylamino]-5-methyl-benzoic acid | | Formula: | C23 H19 Cl N4 O5 S | | SMILES: | Cc1ccc(N[S](=O)(=O)c2ccc(CNC(=O)c3n[nH]c4ccccc34)c(Cl)c2)c(c1)C(O)=O | | InChi: | InChI=1S/C23H19ClN4O5S/c1-13-6-9-20(17(10-13)23(30)31)28-34(32,33)15-8-7-14(18(24)11-15)12-25-22(29)21-16-4-2-3-5-19(16)26-27-21/h2-11,28H,12H2,1H3,(H,25,29)(H,26,27)(H,30,31) | | Definition date: | 2020-06-10 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 2-[[3-chloranyl-4-[(1~{H}-indazol-3-ylcarbonylamino)methyl]phenyl]sulfonylamino]-5-methyl-benzoic acid |
|
 | | QEN | | Name: | 5-bromanyl-2-(naphthalen-2-ylsulfonylamino)benzoic acid | | Formula: | C17 H12 Br N O4 S | | SMILES: | OC(=O)c1cc(Br)ccc1N[S](=O)(=O)c2ccc3ccccc3c2 | | InChi: | InChI=1S/C17H12BrNO4S/c18-13-6-8-16(15(10-13)17(20)21)19-24(22,23)14-7-5-11-3-1-2-4-12(11)9-14/h1-10,19H,(H,20,21) | | Definition date: | 2020-06-10 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 5-bromanyl-2-(naphthalen-2-ylsulfonylamino)benzoic acid |
|
 | | QEZ | | Name: | 5-bromanyl-2-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonylamino)benzoic acid | | Formula: | C17 H16 Br N O4 S | | SMILES: | OC(=O)c1cc(Br)ccc1N[S](=O)(=O)c2ccc3CCCCc3c2 | | InChi: | InChI=1S/C17H16BrNO4S/c18-13-6-8-16(15(10-13)17(20)21)19-24(22,23)14-7-5-11-3-1-2-4-12(11)9-14/h5-10,19H,1-4H2,(H,20,21) | | Definition date: | 2020-06-11 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 5-bromanyl-2-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonylamino)benzoic acid |
|
 | | QF8 | | Name: | ~{N},1-dimethyl-5-[[4-[3-methyl-4-[[(3~{R})-pyrrolidin-3-yl]amino]pyrazol-1-yl]pyrimidin-2-yl]amino]indazole-3-carboxamide | | Formula: | C22 H26 N10 O | | SMILES: | CNC(=O)c1nn(C)c2ccc(Nc3nccc(n3)n4cc(N[CH]5CCNC5)c(C)n4)cc12 | | InChi: | InChI=1S/C22H26N10O/c1-13-17(26-15-6-8-24-11-15)12-32(29-13)19-7-9-25-22(28-19)27-14-4-5-18-16(10-14)20(21(33)23-2)30-31(18)3/h4-5,7,9-10,12,15,24,26H,6,8,11H2,1-3H3,(H,23,33)(H,25,27,28)/t15-/m1/s1 | | Definition date: | 2020-06-15 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | ~{N},1-dimethyl-5-[[4-[3-methyl-4-[[(3~{R})-pyrrolidin-3-yl]amino]pyrazol-1-yl]pyrimidin-2-yl]amino]indazole-3-carboxamide |
|
 | | QFB | | Name: | 7-[[4-[4-[[(3~{R},4~{R})-3-azanyloxan-4-yl]amino]pyrazol-1-yl]pyrimidin-2-yl]amino]-~{N},3-dimethyl-imidazo[1,5-a]pyridine-1-carboxamide | | Formula: | C22 H26 N10 O2 | | SMILES: | CNC(=O)c1nc(C)n2ccc(Nc3nccc(n3)n4cc(N[CH]5CCOC[CH]5N)cn4)cc12 | | InChi: | InChI=1S/C22H26N10O2/c1-13-27-20(21(33)24-2)18-9-14(4-7-31(13)18)29-22-25-6-3-19(30-22)32-11-15(10-26-32)28-17-5-8-34-12-16(17)23/h3-4,6-7,9-11,16-17,28H,5,8,12,23H2,1-2H3,(H,24,33)(H,25,29,30)/t16-,17+/m0/s1 | | Definition date: | 2020-06-15 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 7-[[4-[4-[[(3~{R},4~{R})-3-azanyloxan-4-yl]amino]pyrazol-1-yl]pyrimidin-2-yl]amino]-~{N},3-dimethyl-imidazo[1,5-a]pyridine-1-carboxamide |
|
 | | QFE | | Name: | (3~{R},4~{R})-~{N}4-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]oxane-3,4-diamine | | Formula: | C23 H24 N8 O | | SMILES: | Cn1ccc2c1cccc2c3[nH]c4nccc(n5cc(N[CH]6CCOC[CH]6N)cn5)c4n3 | | InChi: | InChI=1S/C23H24N8O/c1-30-9-6-15-16(3-2-4-19(15)30)22-28-21-20(5-8-25-23(21)29-22)31-12-14(11-26-31)27-18-7-10-32-13-17(18)24/h2-6,8-9,11-12,17-18,27H,7,10,13,24H2,1H3,(H,25,28,29)/t17-,18+/m0/s1 | | Definition date: | 2020-06-15 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | (3~{R},4~{R})-~{N}4-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]oxane-3,4-diamine |
|
 | | QFK | | Name: | 7-[[4-[4-[(dimethylamino)methyl]pyrazol-1-yl]pyrimidin-2-yl]amino]-~{N},3-dimethyl-imidazo[1,5-a]pyridine-1-carboxamide | | Formula: | C20 H23 N9 O | | SMILES: | CNC(=O)c1nc(C)n2ccc(Nc3nccc(n3)n4cc(CN(C)C)cn4)cc12 | | InChi: | InChI=1S/C20H23N9O/c1-13-24-18(19(30)21-2)16-9-15(6-8-28(13)16)25-20-22-7-5-17(26-20)29-12-14(10-23-29)11-27(3)4/h5-10,12H,11H2,1-4H3,(H,21,30)(H,22,25,26) | | Definition date: | 2020-06-15 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 7-[[4-[4-[(dimethylamino)methyl]pyrazol-1-yl]pyrimidin-2-yl]amino]-~{N},3-dimethyl-imidazo[1,5-a]pyridine-1-carboxamide |
|
 | | QFQ | | Name: | ~{N},1-dimethyl-5-[[4-[3-methyl-4-[[(3~{R})-piperidin-3-yl]amino]pyrazol-1-yl]pyrimidin-2-yl]amino]indazole-3-carboxamide | | Formula: | C23 H28 N10 O | | SMILES: | CNC(=O)c1nn(C)c2ccc(Nc3nccc(n3)n4cc(N[CH]5CCCNC5)c(C)n4)cc12 | | InChi: | InChI=1S/C23H28N10O/c1-14-18(27-16-5-4-9-25-12-16)13-33(30-14)20-8-10-26-23(29-20)28-15-6-7-19-17(11-15)21(22(34)24-2)31-32(19)3/h6-8,10-11,13,16,25,27H,4-5,9,12H2,1-3H3,(H,24,34)(H,26,28,29)/t16-/m1/s1 | | Definition date: | 2020-06-15 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | ~{N},1-dimethyl-5-[[4-[3-methyl-4-[[(3~{R})-piperidin-3-yl]amino]pyrazol-1-yl]pyrimidin-2-yl]amino]indazole-3-carboxamide |
|
 | | NL3 | | Name: | 3-{[6-(7-chloro-1-benzothiophen-2-yl)-1H-indol-1-yl]methyl}-1H-pyrazole-5-carboxylic acid | | Formula: | C21 H14 Cl N3 O2 S | | SMILES: | O=C(O)c1cc(n[NH]1)Cn1ccc2ccc(cc21)c1cc2cccc(Cl)c2s1 | | InChi: | InChI=1S/C21H14ClN3O2S/c22-16-3-1-2-14-9-19(28-20(14)16)13-5-4-12-6-7-25(18(12)8-13)11-15-10-17(21(26)27)24-23-15/h1-10H,11H2,(H,23,24)(H,26,27) | | Definition date: | 2021-04-05 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 3-{[6-(7-chloro-1-benzothiophen-2-yl)-1H-indol-1-yl]methyl}-1H-pyrazole-5-carboxylic acid |
|
 | | H9U | | Name: | (2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-3-[(2S,3R,4R,5S,6R)-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-2-(hydroxymethyl)-6-oxidanyl-oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid | | Formula: | C27 H44 N4 O17 | | SMILES: | C[CH](NC(=O)[CH](C)O[CH]1[CH](NC(C)=O)[CH](O)O[CH](CO)[CH]1O[CH]2O[CH](CO)[CH](O)[CH](O)[CH]2NC(C)=O)C(=O)N[CH](CCC(O)=O)C(O)=O | | InChi: | InChI=1S/C27H44N4O17/c1-9(23(40)31-13(25(42)43)5-6-16(36)37)28-24(41)10(2)45-22-18(30-12(4)35)26(44)46-15(8-33)21(22)48-27-17(29-11(3)34)20(39)19(38)14(7-32)47-27/h9-10,13-15,17-22,26-27,32-33,38-39,44H,5-8H2,1-4H3,(H,28,41)(H,29,34)(H,30,35)(H,31,40)(H,36,37)(H,42,43)/t9-,10+,13+,14+,15+,17+,18+,19+,20+,21+,22+,26-,27-/m0/s1 | | Definition date: | 2020-12-11 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | (2~{R})-2-[[(2~{S})-2-[[(2~{R})-2-[(2~{R},3~{S},4~{R},5~{R},6~{S})-5-acetamido-3-[(2~{S},3~{R},4~{R},5~{S},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-2-(hydroxymethyl)-6-oxidanyl-oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid |
|
 | | HG0 | | Name: | N-[bis(azanyl)methylidene]-3-methylsulfonyl-4-propan-2-yl-benzamide | | Formula: | C12 H17 N3 O3 S | | SMILES: | CC(C)c1ccc(cc1[S](C)(=O)=O)C(=O)N=C(N)N | | InChi: | InChI=1S/C12H17N3O3S/c1-7(2)9-5-4-8(11(16)15-12(13)14)6-10(9)19(3,17)18/h4-7H,1-3H3,(H4,13,14,15,16) | | Definition date: | 2021-01-07 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | ~{N}-[bis(azanyl)methylidene]-3-methylsulfonyl-4-propan-2-yl-benzamide |
|
 | | LB6 | | Name: | N-[(6-bromo-1H-indol-1-yl)acetyl]glycine | | Formula: | C12 H11 Br N2 O3 | | SMILES: | O=C(O)CNC(=O)Cn1ccc2ccc(Br)cc21 | | InChi: | InChI=1S/C12H11BrN2O3/c13-9-2-1-8-3-4-15(10(8)5-9)7-11(16)14-6-12(17)18/h1-5H,6-7H2,(H,14,16)(H,17,18) | | Definition date: | 2021-04-05 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | N-[(6-bromo-1H-indol-1-yl)acetyl]glycine |
|
 | | V31 | | Name: | 5-bromanyl-2-[(phenylmethyl)sulfonylamino]benzoic acid | | Formula: | C14 H12 Br N O4 S | | SMILES: | OC(=O)c1cc(Br)ccc1N[S](=O)(=O)Cc2ccccc2 | | InChi: | InChI=1S/C14H12BrNO4S/c15-11-6-7-13(12(8-11)14(17)18)16-21(19,20)9-10-4-2-1-3-5-10/h1-8,16H,9H2,(H,17,18) | | Definition date: | 2020-06-10 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | 5-bromanyl-2-[(phenylmethyl)sulfonylamino]benzoic acid |
|
 | | V41 | | Name: | (2R,3Z)-3-amino-3-imino-2-[(E)-phenyldiazenyl]propanamide | | Formula: | C9 H11 N5 O | | SMILES: | N(=N/C(C(N)=O)/C(N)=N)c1ccccc1 | | InChi: | InChI=1S/C9H11N5O/c10-8(11)7(9(12)15)14-13-6-4-2-1-3-5-6/h1-5,7H,(H3,10,11)(H2,12,15)/b14-13+/t7-/m1/s1 | | Definition date: | 2020-06-22 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | (2R,3Z)-3-amino-3-imino-2-[(E)-phenyldiazenyl]propanamide |
|
 | | AEU | | Name: | N-[(3-phenoxyphenyl)methyl]-9H-beta-carbolin-3-amine | | Formula: | C24 H19 N3 O | | SMILES: | c1c5c(cc(n1)NCc2cccc(c2)Oc3ccccc3)c4ccccc4n5 | | InChi: | InChI=1S/C24H19N3O/c1-2-8-18(9-3-1)28-19-10-6-7-17(13-19)15-25-24-14-21-20-11-4-5-12-22(20)27-23(21)16-26-24/h1-14,16,27H,15H2,(H,25,26) | | Definition date: | 2018-10-31 | | Last modified: | 2021-06-18 | | Release date: | 2021-06-23 | | Identifier: | N-[(3-phenoxyphenyl)methyl]-9H-beta-carbolin-3-amine |
|
 | | XKG | | Name: | (2E)-9,10-dimethoxy-3-methyl-2-[(2,4,6-trimethylphenyl)imino]-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one | | Formula: | C24 H27 N3 O3 | | SMILES: | Cc1cc(c(c(c1)C)N=C4/C=C3c2c(cc(c(c2)OC)OC)CCN3C(=O)N4C)C | | InChi: | InChI=1S/C24H27N3O3/c1-14-9-15(2)23(16(3)10-14)25-22-13-19-18-12-21(30-6)20(29-5)11-17(18)7-8-27(19)24(28)26(22)4/h9-13H,7-8H2,1-6H3/b25-22+ | | Synonyms: | Trequinsin | | Definition date: | 2020-12-17 | | Last modified: | 2021-06-11 | | Release date: | 2021-06-16 | | Identifier: | (2E)-9,10-dimethoxy-3-methyl-2-[(2,4,6-trimethylphenyl)imino]-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one |
|
 | | YP1 | | Name: | 2-chloro-6-[(2R)-2-hydroxy-3-{[2-methyl-1-(naphthalen-2-yl)propan-2-yl]amino}propoxy]benzonitrile | | Formula: | C24 H25 Cl N2 O2 | | SMILES: | N#Cc1c(cccc1Cl)OCC(O)CNC(C)(C)Cc1cc2ccccc2cc1 | | InChi: | InChI=1S/C24H25ClN2O2/c1-24(2,13-17-10-11-18-6-3-4-7-19(18)12-17)27-15-20(28)16-29-23-9-5-8-22(25)21(23)14-26/h3-12,20,27-28H,13,15-16H2,1-2H3/t20-/m1/s1 | | Definition date: | 2021-03-18 | | Last modified: | 2021-06-11 | | Release date: | 2021-06-16 | | Identifier: | 2-chloro-6-[(2R)-2-hydroxy-3-{[2-methyl-1-(naphthalen-2-yl)propan-2-yl]amino}propoxy]benzonitrile |
|
 | | ZB4 | | Name: | N-{(1S,2S)-2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide | | Formula: | C23 H31 N3 O3 S | | SMILES: | O=S(=O)(NC1CCCCC1N1CCN(CC1)c1ccccc1OC)c1ccccc1 | | InChi: | InChI=1S/C23H31N3O3S/c1-29-23-14-8-7-13-22(23)26-17-15-25(16-18-26)21-12-6-5-11-20(21)24-30(27,28)19-9-3-2-4-10-19/h2-4,7-10,13-14,20-21,24H,5-6,11-12,15-18H2,1H3/t20-,21-/m0/s1 | | Definition date: | 2021-04-13 | | Last modified: | 2021-06-11 | | Release date: | 2021-06-16 | | Identifier: | N-{(1S,2S)-2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide |
|
 | | WU4 | | Name: | (6aR,7aS,11S,13aS)-6,6,11-trimethyl-4-(3-methylbut-2-en-1-yl)-6,6a,7,8,9,10,11,14-octahydro-5H,13H-13a,7a-(epiminomethano)quinolizino[2,3-b]carbazol-16-one | | Formula: | C28 H37 N3 O | | SMILES: | N2C(=O)C51N(C(CCC1)C)CC24Cc6c3c(c(ccc3)CC=C(/C)C)nc6C(C)(C)C4C5 | | InChi: | InChI=1S/C28H37N3O/c1-17(2)11-12-19-9-6-10-20-21-14-27-16-31-18(3)8-7-13-28(31,25(32)30-27)15-22(27)26(4,5)24(21)29-23(19)20/h6,9-11,18,22,29H,7-8,12-16H2,1-5H3,(H,30,32)/t18-,22+,27+,28-/m0/s1 | | Definition date: | 2020-11-13 | | Last modified: | 2021-06-11 | | Release date: | 2021-06-16 | | Identifier: | (6aR,7aS,11S,13aS)-6,6,11-trimethyl-4-(3-methylbut-2-en-1-yl)-6,6a,7,8,9,10,11,14-octahydro-5H,13H-13a,7a-(epiminomethano)quinolizino[2,3-b]carbazol-16-one |
|
 | | YSY | | Name: | 4-[(4R,5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile | | Formula: | C13 H10 F N3 | | SMILES: | N#Cc1ccc(C2CCc3cncn32)c(F)c1 | | InChi: | InChI=1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2/t13-/m1/s1 | | Synonyms: | Osilodrostat | | Definition date: | 2021-03-31 | | Last modified: | 2021-06-11 | | Release date: | 2021-06-16 | | Identifier: | 4-[(4R,5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile |
|